Company profile for DISCO Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At DISCO, our capability extends to systematically unlocking the entire cancer cell surface on a large scale. We achieve this by identifying surface-bound proteins and revealing intricate protein communities. This innovative approach allows us to unveil comprehensive target information that goes beyond the capabilities of standard proteomics, genome sequencing, or transcriptome sequencing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/disco-pharmaceuticals-launches-as-the-surfaceome-company-with-eur-20-million-in-seed-financing-302035543.html

PR NEWSWIRE
16 Jan 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty